Cyclodextrin Market Research, 2032
The global cyclodextrin market was valued at $334 million in 2022, and is projected to reach $579.6 million by 2032, growing at a CAGR of 5.7% from 2023 to 2032.
Report Key Highlighters:
The report provides competitive dynamics by evaluating business segments, product portfolios, target market revenue, geographical presence and key strategic developments by prominent manufacturers.
The global cyclodextrin market is fragmented in nature among prominent companies such as Cambrex Corporation, Cayman Chemical, Wellona Pharma, Wacker Chemie AG, Cyclolab, Tocopharm Co. Limited, Roquette FrÃres, Midas Pharma GmbH, Ligand Pharmaceuticals Incorporated, and Cyclo Therapeutics, Inc.
The study contains qualitative information such as the market dynamics (drivers, restraints, challenges, and opportunities), key regulation analysis, pricing analysis, and Porters five force analysis across North America, Europe, Asia-Pacific, LAMEA regions.
Latest trends in global cyclodextrin market such as undergoing R&D activities, regulatory guidelines, and government initiatives are analyzed across 16 countries in 4 different regions.
More than 3,200 cyclodextrin-related product literatures, industry releases, annual reports, and other such documents of key industry participants along with authentic industry journals and government websites have been reviewed for generating high-value industry insights for global cyclodextrin market.
Cyclodextrins are a family of cyclic oligosaccharides, which are composed of glucose units linked together by alpha-1,4-glycosidic bonds. These molecules have a unique structure resembling a truncated cone or torus with a hydrophobic central cavity and a hydrophilic outer surface. This structural arrangement results in the formation of a three-dimensional molecular container.
The most common types of cyclodextrins include alpha-cyclodextrin, beta-cyclodextrin, and gamma-cyclodextrin. Each type differs in the number of glucose units it contains, influencing the size of its central cavity.
Cyclodextrins are produced through the enzymatic degradation of starch by certain bacteria or through chemical modification processes. Due to their unique structure, cyclodextrins have various applications in different industries, including pharmaceuticals, food, cosmetics, and more.
One of the primary drivers of the cyclodextrin market is its extensive use in the pharmaceutical industry. Cyclodextrins are widely employed to enhance the solubility and bioavailability of poorly soluble drugs. For instance, according to a report published by India Brands Equity Foundation, the Indian pharmaceutical industry witnessed a growth of 17.7% in 2021 and is expected to grow by 22% by the end of 2022. As pharmaceutical companies continue to develop new drugs with challenging physicochemical properties, the demand for cyclodextrins as pharmaceutical excipients increases. This is particularly crucial in the formulation of oral, topical, and parenteral drug delivery systems.
Furthermore, the advancements in drug delivery systems have been a significant driver for the cyclodextrin market. Cyclodextrins play a pivotal role in improving the stability, solubility, and release profile of drugs. Inclusion complexes formed by cyclodextrins allow for the controlled release of active pharmaceutical ingredients (APIs), leading to enhanced therapeutic outcomes. The demand for innovative drug delivery solutions and sustained-release formulations further boosts the utilization of cyclodextrins.
However, one prominent restraint is the cost associated with cyclodextrin production. The manufacturing process involves enzymatic conversion of starch, usually derived from crops like corn or potatoes, into cyclodextrins. Fluctuations in raw material prices, coupled with the energy-intensive production process, contribute to the overall cost of cyclodextrins. As a result, end-users may find alternative solutions or formulations that are more cost-effective, limiting the widespread adoption of cyclodextrins.
Moreover, another restraint associated with the cyclodextrin market is the cost associated with cyclodextrin production. The manufacturing process involves enzymatic conversion of starch, usually derived from crops like corn or potatoes, into cyclodextrins. Fluctuations in raw material prices, coupled with the energy-intensive production process, contribute to the overall cost of cyclodextrins. As a result, end-users may find alternative solutions or formulations that are more cost-effective, limiting the widespread adoption of cyclodextrins.
On the contrary, in the textile industry, cyclodextrins are utilized for various purposes, including dye solubilization and fragrance encapsulation in fabrics. According to a report published by National Council of Textile Organization in 2022, the U.S. textile and apparel shipments totaled $65.8 billion in 2022 and became the third largest exporter of textile-related products in the world. The textile sector's continuous efforts to develop functional and value-added products contribute to the adoption of cyclodextrins in textile applications.
The global cyclodextrin market is segmented on the basis of type, end-user industry, and region. On the basis of type, the market is categorized into alpha-cyclodextrin, beta-cyclodextrin, and gamma-cyclodextrin. On the basis of end-user industry, it is divided into food, pharmaceutical, cosmetics & personal care, chemical, textile, and others. Region-wise, the market is studied across North America, Europe, Asia-Pacific, and LAMEA.
In 2022, the beta-cyclodextrin segment was the largest revenue generator and is anticipated to grow at a high CAGR during the forecast period. Beta-cyclodextrin is widely used in the pharmaceutical industry for drug delivery. Its ability to form inclusion complexes with various drugs helps improve their solubility, stability, and bioavailability. As pharmaceutical research continues to advance, the demand for beta-cyclodextrin in drug formulation may increase.
By end-user industry, the pharmaceutical segment dominated the global market in 2022, and is anticipated to grow at a CAGR of 6.2% during forecast period. One of the major challenges in drug development is the poor solubility of many drugs. Cyclodextrins can encapsulate hydrophobic drugs within their hydrophobic core, improving their solubility in water. This enhanced solubility can lead to better bioavailability and more effective drug delivery.
The Asia-Pacific cyclodextrin market size is projected to grow at the highest CAGR during the forecast period. Cyclodextrins are commonly used in the pharmaceutical industry to improve the solubility and stability of poorly water-soluble drugs. With a growing pharmaceutical sector in the Asia-Pacific region, there is an increased demand for cyclodextrins to enhance the bioavailability of pharmaceutical formulations.
The global cyclodextrin market profiles leading players that include Cambrex Corporation, Cayman Chemical, Wellona Pharma, Wacker Chemie AG, Cyclolab, Tocopharm Co. Limited, Roquette FrÃres, Midas Pharma GmbH, Ligand Pharmaceuticals Incorporated, and Cyclo Therapeutics, Inc.
Other key players involved in the manufacturing of cyclodextrin includes Zibo Qianhui biological technology co., ltd, Xi'an Deli Biochemical Industry Co., Ltd, Merck KgaA, Otto Chemie Pvt. Ltd., VIO CHEMICALS, Ashland, and TCI Chemicals Pvt. Ltd. The global cyclodextrin market report provides in-depth competitive analysis as well as profiles of these major players.
Key Benefits For Stakeholders
- This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the cyclodextrin market analysis from 2022 to 2032 to identify the prevailing cyclodextrin market opportunities.
- The market research is offered along with information related to key drivers, restraints, and opportunities.
- Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
- In-depth analysis of the cyclodextrin market segmentation assists to determine the prevailing market opportunities.
- Major countries in each region are mapped according to their revenue contribution to the global market.
- Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
- The report includes the analysis of the regional as well as global cyclodextrin market trends, key players, market segments, application areas, and market growth strategies.
Cyclodextrin Market Report Highlights
| Aspects | Details |
 Market Size By 2032 | USD 579.6 million |
 Growth Rate | CAGR of 5.7% |
 Forecast period | 2022 - 2032 |
 Report Pages | 354 |
 By Type |
|
 By End-User Industry |
|
 By Region |
|
 Key Market Players | Cayman Chemical Company, Midas Pharma GmbH, Tocopharm Co. Limited, Wellona Pharma Private Limited., Ligand Pharmaceuticals Incorporated, Cambrex Corporation, Cyclo Therapeutics, Inc, Roquette Freres, Cyclolab, Wacker Chemie AG. |
Analyst Review
According to the CXOs of leading companies, the cyclodextrin market is driven by a combination of factors spanning diverse industries. From pharmaceutical advancements to the demand for sustainable solutions and continuous research initiatives, these drivers collectively contribute to the growth and evolution of the cyclodextrin market. As industries continue to seek innovative solutions to address challenges, the versatility and unique properties of cyclodextrins position them as valuable components in various applications.
While the cyclodextrin market shows promise and growth potential, addressing these restraints is essential for sustained success. Overcoming challenges related to production costs, regulatory compliance, awareness, and competition will require collaborative efforts from industry stakeholders, including manufacturers, researchers, and regulatory bodies, to foster a more favorable environment for cyclodextrin adoption and innovation.
Robust demand from food & beverage sector, increasing nutraceutical applications, and rise in demand from pharmaceutical sector are the upcoming trends of cyclodextrin market in the world.
The pharmaceuticals is the leading applications of the cyclodextrin market.
North America is the largest regional market for cyclodextrin.
The global cyclodextrin market was valued at $334.0 million in 2022 and is estimated to reach $579.6 million by 2032, exhibiting a CAGR of 5.7% from 2023 to 2032.
Cambrex Corporation, Cayman Chemical, Wellona Pharma, Wacker Chemie AG, Cyclolab, Tocopharm Co. Limited, Roquette Frères, Midas Pharma GmbH, Ligand Pharmaceuticals Incorporated, and Cyclo Therapeutics, Inc. are the top companies to hold the market share in the cyclodextrin market.
Loading Table Of Content...
Loading Research Methodology...
